(Q46425875)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18708242%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

title

KIT activation in uterine cervix adenosquamous carcinomas by KIT/SCF autocrine/paracrine stimulation loops (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18708242%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18708242%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Fernando Schmitt

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18708242%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Fernando Schmitt

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18708242%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Rui Manuel Reis

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18708242%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Adhemar Longatto-Filho

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18708242%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

author name string

Alberto Gonçalves

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18708242%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Marise A R Moreira

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18708242%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Luiz F J Ribeiro

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18708242%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Geraldo S Queiroz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18708242%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

language of work or name

English

0 references

publication date

16 August 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18708242%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18708242%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

volume

111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18708242%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18708242%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

page(s)

350-355

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18708242%20AND%20SRC:MED&resulttype=core&format=json

Investigation of human papillomavirus by hybrid capture II in cervical carcinomas including 113 adenocarcinomas and related lesions

12 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

Adenosquamous histology predicts poor outcome in low-risk stage IB1 cervical adenocarcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

The epidemiology of human papillomavirus infection and cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

Papillomaviruses and cancer: from basic studies to clinical application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

Molecular characterization of adenocarcinoma and squamous carcinoma of the uterine cervix using microarray analysis of gene expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

Cyclooxygenase-2 and Epidermal Growth Factor Receptor Expressions in Different Histological Subtypes of Cervical Carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

Lymphatic vessel density and epithelial D2-40 immunoreactivity in pre-invasive and invasive lesions of the uterine cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

The discovery of receptor tyrosine kinases: targets for cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

Oncogenic kinase signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

Kit as a human oncogenic tyrosine kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

Activating c-kit gene mutations in human germ cell tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

Signal transducer and activator of transcription 3 activation is required for Asp(816) mutant c-Kit-mediated cytokine-independent survival and proliferation in human leukemia cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

KIT gene in pediatric osteosarcomas: could it be a new therapeutic target?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

Co expression of SCF and KIT in gastrointestinal stromal tumours (GISTs) suggests an autocrine/paracrine mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

Growth stimulation of colorectal carcinoma cells via the c-kit receptor is inhibited by TGF-beta 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

Coexpression of c-kit and stem cell factor in breast cancer results in enhanced sensitivity to members of the EGF family of growth factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

Overexpression of c-kit protein is an infrequent event in small cell carcinomas of the uterine cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

Interleukin-2 (IL-2) receptor-betagamma signalling is activated by c-Kit in the absence of IL-2, or by exogenous IL-2 via JAK3/STAT5 in human papillomavirus-associated cervical cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

Molecular Analysis of c-KitandPDGFRAin GISTs Diagnosed by EUS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

Mutation analysis of B-RAF gene in human gliomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

Expression of platelet derived growth factor family members and the potential role of imatinib mesylate for cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

Sunitinib for imatinib-resistant GIST

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

Sorafenib: delivering a targeted drug to the right targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

Synergistic growth-inhibitory effects of two tyrosine kinase inhibitors, dasatinib and PKC412, on neoplastic mast cells expressing the D816V-mutated oncogenic variant of KIT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.011

10.1016/J.YGYNO.2008.07.011

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18708242%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference